Evaluation of early response to entecavir (ETV) in a mixed HBV genotype cohort.
ETV pharmacokinetic evaluation in a clinical ‘real-life’ context.
Study of the concentration–effect relationship of anti-HBV treatment with ETV.
Evidence of inverse correlation between ETV concentrations and response.
Definition of an ETV plasma cut-off concentration for rapid response.